Clinical trial data platform
ClinicalTrials.gov (global)
594,309
Studies (totalCount)
Ongoing trials by phase
1,850
Early Phase 1 (preclinical)
11,125
Phase 1
18,768
Phase 2
7,990
Phase 3
Completed trials
324,591
Completed (overall status)
Last synced: 2026-07-17 15:49:12 (UTC server time).
Recently FDA-approved drugs
SODIUM BICARBONATE
- Ingredient
- SODIUM BICARBONATE
- Approval
- 2026-07-09
- Application
- NDA220790
- Sponsor
- AMNEAL EU LTD
ZAYNICH
- Ingredient
- ZIDEBACTAM DIHYDRATE AND CEFEPIME HYDROCHLORIDE
- Approval
- 2026-05-29
- Application
- NDA220787
- Sponsor
- WOCKHARDT BIO AG
DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)
- Ingredient
- ADAPALENE AND BENZOYL PEROXIDE
- Approval
- 2026-05-22
- Application
- NDA220736
- Sponsor
- GALDERMA LABS LP
BEQALZI
- Ingredient
- SONROTOCLAX
- Approval
- 2026-05-13
- Application
- NDA220711
- Sponsor
- BEONE MEDICINES USA
EVDI
- Ingredient
- TRABECTEDIN
- Approval
- 2026-05-01
- Application
- NDA220837
- Sponsor
- APOTEX
DULOXETINE HYDROCHLORIDE
- Ingredient
- DULOXETINE
- Approval
- 2026-02-27
- Application
- NDA219131
- Sponsor
- ALMATICA
Recently completed Phase 3 trials
Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy
- Topic
- Hemophilia B
- Start
- 2024-07-28
- Completion
- 2026-07-07
- Sponsor
- CSL Behring
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
- Topic
- Childhood Absence Epilepsy
- Start
- 2021-07-29
- Completion
- 2026-07-07
- Sponsor
- UCB Biopharma SRL
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
- Topic
- Active Idiopathic Inflammatory Myopathy
- Start
- 2022-10-12
- Completion
- 2026-07-02
- Sponsor
- argenx
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
- Topic
- Transitional Cell Cancer of Renal Pelvis and Ureter
- Start
- 2021-03-22
- Completion
- 2026-07-01
- Sponsor
- Steba Biotech S.A.
Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ
- Topic
- Gastroesophageal Junction Adenocarcinoma
- Start
- 2020-06-03
- Completion
- 2026-06-30
- Sponsor
- Universitätsmedizin Mannheim
Open-Label Extension Study of Setmelanotide
- Topic
- Obesity Associated With Defects in Leptin-melanocortin Pathway
- Start
- 2024-10-21
- Completion
- 2026-06-24
- Sponsor
- Rhythm Pharmaceuticals, Inc.
ClinicalTrials.gov search results
- NCT07244770ACTIVE_NOT_RECRUITINGOBSERVATIONAL
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients - NCT06904066RECRUITINGINTERVENTIONALPHASE1
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies - NCT07726082RECRUITINGINTERVENTIONALNA
Micro-choice-based Intervention for Multicausal Fatigue - NCT03223753COMPLETEDINTERVENTIONALPHASE3
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer - NCT01696994ACTIVE_NOT_RECRUITINGINTERVENTIONALNA
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) - NCT06316739ACTIVE_NOT_RECRUITINGINTERVENTIONALNA
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City - NCT07726199RECRUITINGINTERVENTIONALNA
Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread - NCT07332507RECRUITINGINTERVENTIONALPHASE1
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma - NCT07494734ENROLLING_BY_INVITATIONINTERVENTIONALNA
MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE - NCT06487481RECRUITINGINTERVENTIONALPHASE1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma - NCT07726004NOT_YET_RECRUITINGINTERVENTIONALNA
Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women - NCT00565344COMPLETEDOBSERVATIONAL
Medicaid Disenrollment: Intrastate Emergency Department Impact - NCT07725705NOT_YET_RECRUITINGINTERVENTIONALPHASE1, PHASE2
SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL) - NCT07561346COMPLETEDOBSERVATIONAL
Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer - NCT03219359RECRUITINGINTERVENTIONALPHASE2
Autologous Stem Cell Transplant for Crohn's Disease - NCT05201066ACTIVE_NOT_RECRUITINGINTERVENTIONALPHASE2
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. - NCT04203173COMPLETEDINTERVENTIONALNA
Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 - NCT07725562RECRUITINGINTERVENTIONALPHASE2, PHASE3
Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage Parkinson's Disease - NCT07725146RECRUITINGOBSERVATIONAL
Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire - NCT07190794TERMINATEDOBSERVATIONAL
RESCUE: Discontinuation of GLP-1
MediTrans services
Request data-backed reports, medical writing, or custom clinical intelligence deliverables.
Sign in with Kakao to continue